r/neurology • u/Brighter-Side-News • 23h ago
Clinical FDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team
thebrighterside.newsA once-daily Parkinson’s pill has reached FDA approval after decades of work on a dopamine pathway that early treatments largely overlooked.
Tavapadon, sold as Juvmo, offers adults another way to manage movement symptoms, either alone or alongside levodopa. It directly stimulates selected dopamine receptors instead of being converted into dopamine. The approval expands treatment options without establishing a cure or a way to halt the disease.
The FDA approved the drug September 25, and AbbVie announced plans to make it available in October. Research by University of Virginia scientists Richard Mailman and Xuemei Huang helped establish the case for targeting D1-like receptors.
The clinical evidence is published in TEMPO-1, TEMPO-2, TEMPO-3 and TEMPO-4 studies. Those trials tested symptom control in early Parkinson’s and in people experiencing fluctuations while taking levodopa.